Navigation Links
Living with salt

Over the years, a number of Weizmann Institute scientists have addressed the question of how molecules essential to life, such as proteins, have adapted to function in extreme environments. The proteins they investigated were isolated from halophilic (salt-loving) microorganisms from the Dead Sea. After determining the 3-D structures for several halophilic proteins, researchers were able to explain how these proteins not only cope with high salinities, but are actually "addicted" to them. However, the alga Dunaliella salina is an organism of a different streak: it is able to grow in any salinity, from the extremes of the Dead Sea to nearly fresh water. The uniquely salt-tolerant Dunaliella, which is commercially grown as a source of natural beta carotene, has been investigated at the Weizmann Institute for over 30 years. Yet, the secrets of its exceptionally successful adaptation to salt remained unresolved.

In a recent paper published in the Proceedings of the National Academy of Sciences, USA (PNAS), Institute scientists Prof. Ada Zamir and Dr. Lakshmanane Premkumar of the Institute's Biological Chemistry Department and Prof. Joel Sussman and Dr. Harry Greenblatt of the Structural Biology Department revealed the structural basis of a remarkably salt-tolerant Dunaliella enzyme, a carbonic anhydrase, which may hold the key. Comparisons with known carbon anhydrases from animal sources showed that the Dunaliella enzyme shares a basic plan with its distant relatives, but with a few obvious differences. The most striking of these is in the electrical charges on the proteins' surfaces: Charges on the salt-tolerant enzyme are uniformly negative (though not as intensely negative as those in halophilic proteins), while the surfaces of carbonic anhydrases that don't tolerate salt sport a negative/positive/ neutral mix. This and other unique structural features may enable the algal carbonic anhydrase to be active in the presence of salt, though not dependent on it. In a surprise twist, the researchers discovered that one other known carbonic anhydrase - found in mouse kidney - sported a similar, salt-tolerant construction. Pondering why a structure conferring salt tolerance should evolve once in a Dead Sea organism and once in a mouse has led the researchers to some new insights into kidney physiology. The researchers hope that the knowledge gleaned from their study of a tiny alga might provide the basis for designing new drugs that could target enzymes based on their salt tolerance.

Prof. Joel Sussman's research is funded by the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly; the Joseph and Ceil Mazer Center for Structural Biology; the Charles A. Dana Foundation; the Divadol Foundation; the Jean and Jula Goldwurm Memorial Foundation; the late Sally Schnitzer, New York, NY; the Kalman and Ida Wolens Foundation; and the Wolfson Family Charitable Trust. Prof. Joel Sussman is the incumbent of the Morton and Gladys Pickman Chair in Structural Biology.


'"/>

Source:American Committee for the Weizmann Institute of Science


Related biology news :

1. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
2. Living anti-HIV gel shows early promise
3. Living taste cells produced outside the body
4. Living laboratory found on shoreline statues
5. Study: Living coral reefs provide better protection from tsunami waves
6. Living view in animals shows how cells decide to make proteins
7. Living with water scarcity -- world must act now
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):
(Date:8/17/2017)... Village, CA (PRWEB) , ... August 17, 2017 ... ... technology for cancer research and personalized medicine, today announced the launch of a ... Kansas City, Missouri. The study’s goal is to evaluate the potential for early ...
(Date:8/16/2017)... ... 2017 , ... Today, 3Bar Biologics Inc ., the ... funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio ... investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally occurring ...
(Date:8/15/2017)... NC (PRWEB) , ... August 15, 2017 , ... ... 2017, celebrating 10 years of successes helping medical technology companies and inventors develop and ... to a renowned full-service national engineering firm with a portfolio of clients in the ...
(Date:8/15/2017)... , ... August 15, 2017 , ... The Conference ... on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The ... 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our experience ...
Breaking Biology Technology: